Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-10-19 Purchase |
2022-10-21 7:01 pm |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
15,000 | $5.32 | $79,800 | 15,000 (Direct) |
View |
| 2021-08-06 Sale |
2021-08-10 8:00 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $138.52 | $3,462,926 | 132,891 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:46 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $92.26 | $1,107,068 | 156,410 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:20 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $86.74 | $1,040,919 | 168,410 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-28 Option Award |
2024-08-29 4:15 pm |
N/A 2034-08-28 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:28 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:22 pm |
N/A 2033-06-07 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:25 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | TOMSICEK MICHAEL JOHN Director |
35,235 | $0 | 35,235 (Direct) |
View |
| 2022-07-05 Option Award |
2022-08-11 6:03 pm |
N/A 2032-07-05 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-08-06 Exercise |
2021-08-10 8:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $17.75 | 132,891 (Direct) |
View |
| 2021-03-11 Exercise |
2021-08-10 8:00 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
25,000 | $0 | 132,891 (Direct) |
View |
| 2021-06-14 Option Award |
2021-07-29 5:39 pm |
N/A 2031-06-14 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-03-10 Tax Withholding |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
1,352 | $124.15 | 36,251 (Direct) |
View |
| 2021-03-11 Option Award |
2021-03-12 5:50 pm |
N/A 2031-03-11 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
34,360 | $0 | 36,251 (Direct) |
View |
| 2021-03-10 Exercise |
2021-03-12 5:50 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
2,833 | $0 | 36,251 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-06 5:48 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
11,666 | $0 | 11,666 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:46 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $17.75 | 156,410 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:46 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $0 | 156,410 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:20 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $17.75 | 168,410 (Direct) |
View |
| 2017-11-13 Exercise |
2020-08-05 4:20 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $0 | 168,410 (Direct) |
View |
| 2020-06-05 Option Award |
2020-06-08 7:08 pm |
N/A 2030-06-05 |
Milestone Pharmaceuticals Inc. | MIST | TOMSICEK MICHAEL JOHN Director |
15,000 | $0 | 15,000 (Direct) |
View |